bioRxivNeurosciencePreprint
Multi-omics profiling reveals MAGEL2-driven defects in human corticogenesis shared across Prader-Willi and Schaaf-Yang syndromes.
Jannis BueckingiD, Baran E. GüleriD, Michael EibliD, Azmal Syed Ali, Tobias Walczuch, Tobias Beschauner, Susanne Theiß, Melanie Spanjaard, Katrin HinderhoferiD, Freya Herrmann-Sim, Celine E. de Esch, Derek J.C. TaiiD, Michael E. TalkowskiiD, Jeroen KrijgsveldiD, Christian P. Schaaf, Magdalena LaugschiD
Abstract
The human cortex acquires its advanced cognitive capacity through tightly regulated developmental programs, disruption of which underlies neurodevelopmental disorders such as Schaaf-Yang syndrome (SYS) and Prader-Willi syndrome (PWS). While SYS results from pathogenic variants in the imprinted gene MAGEL2, PWS arises from chromosomal deletions, imprinting defects or uniparental disomy encompassing the MAGEL2 locus. However, the contribution of MAGEL2 to disease pathogenesis and human corticogenesis is not fully understood. Here, we performed integrated transcriptomic, proteomic, and ubiquitinomic profiling of cortical neurons derived from CRISPR/Cas9-engineered isogenic human pluripotent stem cells (hiPSC) modeling SYS and PWS. Beyond PWS-specific signatures including dysregulated ribosomal processes, we identified MAGEL2-dependent defects shared across both disorders. These include reduced progenitor proliferation, accelerated neuronal maturation, impaired migration and adhesion, as well as abnormal synaptic development, collectively linking PWS and SYS at the level of cortical development. Notably, these phenotypes partially overlap with those observed in other neurodevelopmental disorders, suggesting that MAGEL2 governs core pathways broadly vulnerable in disease. Together, our findings establish MAGEL2 as a key regulator of human cortical development, provide a unifying mechanistic framework for SYS and PWS, accessible via a web-based platform.
- organism: human
- assay: bulk RNA-seq
- assay: proteomics
- assay: DNA methylation
- research focus: cell type annotation
- research focus: differential expression
- research focus: gene regulatory network inference
- approach: statistical model
- approach: experimental assay
- Citations
- 1
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Magel2 deficiency drives microglial synaptic engulfment and alters neuron-microglia interactions in Prader-Willi syndrome
Jemima Helen, Moritz Claudius Wimmer, … Ferdinand Althammer·bioRxiv·Sep 30, 2026
- A truncating mutation of Magel2 in the rat modelled for the study of Schaaf-Yang and Prader-Willi syndromes alters select behavioral and physiological outcomes
Derek L. Reznik, Mingxiao V. Yang, … Rodney C. Samaco·bioRxiv·Aug 9, 2022
- Loss of MAGEL2 Disrupts Pituitary Translation in a Mouse Model of PWS and Schaaf-Yang Syndrome
Tara Bayat, Maria Camila Hoyos Sanchez, … Klementina Fon Tacer·bioRxiv·May 14, 2026
- Similar metabolic pathways are affected in both Congenital Myasthenic Syndrome 22 and Prader Willi Syndrome
Kritika Bhalla, Karen Rosier, … John W.M. Creemers·Biochimica et Biophysica Acta (BBA) - Molecular Basis of DiseasePeer-reviewed·Apr 16, 2024
- Subcellular localization of truncated MAGEL2 proteins: insight into the molecular pathology of Schaaf-Yang syndrome
Mónica Centeno-Pla, Estefanía Alcaide-Consuegra, … Susana Balcells·bioRxiv·Jan 22, 2024
- Polycomb Repressive Complex 2 is critical for mouse cortical glutamatergic neuron development
Laura Currey, Benjamin Mitchell, … Michael Piper·Cerebral CortexPeer-reviewed·Jun 16, 2024